Á lódáil...
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study
BACKGROUND AND OBJECTIVES: Surgery followed by gemcitabine and/or a fluoropyrimidine is standard therapy for resectable PDAC. mFOLFIRINOX (oxaliplatin 85 mg/m(2), irinotecan 180 mg/m(2), leucovorin 400 mg/m(2) Day 1, 5-FU 2400 mg/m(2) × 48 h IV, peg-filgrastim 6 mg SQ day 3, every 14 days) has subst...
Na minha lista:
| Foilsithe in: | J Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890423/ https://ncbi.nlm.nih.gov/pubmed/29044544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24872 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|